首页> 外国专利> New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis

New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis

机译:特发性脊柱侧弯严重进展的新标志物及其用于对脊柱侧弯患者进行分层并预测发生脊柱侧弯的风险

摘要

Methods of stratifying a subject having or at risk for developing adolescent idiopathic scoliosis (AIS) into diagnostically or clinically useful subclasses are provided. The stratification is based on the subject's ΡΤΡμ expression and/or activity and/or PIPK1γ expression and/or activity. Also provided are methods of predicting the risk of developing a scoliosis also based on the subject's ΡΤΡμ expression and/or activity and/or PIPK1γ expression and/or activity; and methods of increasing GiPCR signaling in cells of a subject in need thereof comprising administering to the subject's cells an effective amount of an inhibitor of PIPK1γ tyrosine phosphorylation; an activator of PIPK1Y tyrosine dephosphorylation; and/or an inhibitor of PIPK1γ expression and/or activity.
机译:提供了将患有青少年特发性脊柱侧凸(AIS)或处于发展中的风险的个体分层为诊断或临床上有用的亚类的方法。分层基于受试者的PTPμ表达和/或活性和/或PIPK1γ表达和/或活性。还提供了还基于受试者的PTTPμ表达和/或活性和/或PIPK1γ表达和/或活性来预测发展为脊柱侧弯的风险的方法;以及在需要其的受试者的细胞中增加GiPCR信号传导的方法,包括向该受试者的细胞施用有效量的PIPK1γ酪氨酸磷酸化抑制剂; PIPK1Y酪氨酸脱磷酸活化剂;和/或PIPK1γ表达和/或活性的抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号